The startup provides saliva-based DNA testing services utilizing whole-exome sequencing (WES) to identify genetic variations linked to serious health conditions. Their offerings include family DNA test packages that deliver initial health reports for infants and annual insights on nutrition, athleticism, and development, enabling families to proactively manage health risks across generations.
Funding
$750K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Families often lack comprehensive insights into their genetic predispositions, hindering proactive health management across generations. Traditional genetic testing can be expensive and may not provide ongoing, updated information relevant to changing health needs.
Solution
PlumCare offers saliva-based DNA testing services that utilize whole-exome sequencing to identify genetic variations associated with various health conditions. The core product, DNA Advisor, provides initial health reports for both children and adults, delivering personalized insights from genetic advisors. For children, the service analyzes 324 genes, while for adults, 59 genes are analyzed. PlumCare also offers a subscription service that provides annual updates, including carrier screening, medication metabolism analysis, ancestry information, and an expanded DNA Advisor report covering a 950-gene panel.
Target Audience
The primary target audience includes families seeking to proactively manage their health risks and gain insights into their genetic predispositions across generations.
Features
- Whole-exome sequencing to analyze a targeted set of genes relevant to health and wellness
- DNA Advisor report for children, analyzing 324 genes
- DNA Advisor report for adults, analyzing 59 genes
- DNA Advisor+ Subscription providing updated reports annually, including carrier screening, medication metabolism, and ancestry insights
- Expanded DNA Advisor+ report covering a 950-gene panel (available with subscription)
- Carrier screening report analyzing 245 genes related to approximately 200 diseases (available for existing customers)
- Secure handling of personal information with strict security practices